We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Profit-Driven Dialysis Care Reduces Kidney Transplantation Odds

By HospiMedica International staff writers
Posted on 31 Oct 2019
Patients with end-stage kidney disease (ESKD) who undergo dialysis at for-profit institutions are less likely to receive a kidney transplant, according to a new study.

Researchers at Emory University (Atlanta, GA, USA), Kaiser Permanente Georgia (Atlanta, USA), and other institutions conducted a retrospective study involving 1,478,564 patients (median age 66 years, 55.3% male) with ESKD receiving dialysis at one of 6,511 dialysis facilities in the United States between 2000 and 2016. More...
Facilities were classified as for-profit larger chains with more than 1,000 facilities, large for-profit small chains with fewer than 1,000 facilities, small for-profit small chains, for-profit independent facilities, non-profit small chains, and non-profit independent facilities.

The primary exposure was dialysis facility ownership, with the main outcome being access to kidney transplantation, defined as time from initiation of dialysis to placement on the deceased donor kidney transplantation waiting list, receipt of a living donor kidney transplant, or receipt of a deceased donor kidney transplant. The results revealed that 7.4% received dialysis care at 435 non-profit small chain facilities; 5.3% at 324 non-profit independent facilities; 32.7% at 2,239 facilities of larger for-profit chains; 32.6% at 2,082 facilities of large for-profit chain; 15.3% at 997 for-profit small chain facilities; and 6.7% at 434 for-profit independent facilities.

The researchers determined that over the 17-year study period, patients receiving care in for-profit facilities versus non-profit facilities had significantly lower waitlisting. In all, 11.9% of ESKD patients receiving care in non-profit small chain facilities were waitlisted for a kidney transplant, while 29.8% of patients receiving care in non-profit independent dialysis facilities were waitlisted. This is compared to 7% in one for-profit larger chain, 6.2% in another for-profit large chain, 6.6% in for-profit small chains, and 6.9% in for-profit independent facilities. The study was published on September 10, 2019, in JAMA.

“For-profit dialysis facilities have a higher profit margin when they have more patients on dialysis. In non-profit facilities, there is not the same emphasis on profit margins,” said senior author Rachel Patzer, PhD, MPH, of Emory University. “We hypothesize that this leads to fewer referrals for transplant among for-profit dialysis facilities, which may explain why there is a higher rate of wait-listing and living donor transplants among non-profit facilities compared to for-profit dialysis facilities.”

“Patients should advocate for themselves, and ask questions about all treatment options, including transplantation,” concluded Dr. Patzer, who further clarified that “not all patients are candidates for transplant, but patients should make sure to have these conversations with their medical providers to understand the risks, benefits, and steps needed to pursue kidney transplantation as a treatment option.”

Related Links:
Emory University
Kaiser Permanente Georgia


Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Resorbable Bovine Collagen Membrane
GenDerm
Patient Monitoring System
AlarmSense
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Surgical Techniques

view channel
Image: Memo 4D Curve preserves the mitral annulus’s natural three-dimensional motion while supporting remodeling and is available in sizes up to 42 mm for a broad range of mitral pathology. (Photo courtesy of Corcym)

First Human Implant Performed With New Open Mitral Annuloplasty Ring

In mitral valve repair, clinicians aim to preserve the mitral annulus’s three-dimensional motion while providing enough support for effective remodeling. Ring preferences vary between open and closed ... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.